Corbus Pharmaceuticals to Present at Three Upcoming Investor Conferences

Corbus Pharmaceuticals to Present at Three Upcoming Investor Conferences

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will be presenting at three upcoming virtual investor conferences. Read more >>

Share this post